USPTO 2015–2025 USPTO PatentsView US Corporation

Neozyme International, Inc.

USPTO PatentsView assignee record - 16 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators).

RSS updates for this company

The verdict

According to USPTO PatentsView, Neozyme ranks #17,933 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 9 technology areas.

#17,933
of 49,997 US assignees by volume
Top 40%
by Innovation Score (38.5/100)
19.1
avg claims per patent
+350%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17933 · US Corporation #17,933 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 16 grants
  • MID-PACK #17,933/49,997
  • PHOTO-FINISH Namuga
  • CPC-NARROW A01N · 9 areas
  • INNOV-THIN 38.5/100
  • CLAIMS-RICH 19.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +350% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Namuga Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neozyme’s 38.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Neozyme

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Neozyme's Innovation Score is 38.5/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Neozyme?

Each dot is one of Neozyme’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neozyme’s own 19.1 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neozyme vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 15.915.91616.1 121416182022 Granted patents (volume) Avg claims / patent Namuga Co., Ltd. - 16, 15.06NamugaNanjing Legend Biotech Co., Ltd - 16, 21.31Nanjing Legend Bi…Nanotech Energy, Inc. - 16, 19.62Nanotech EnergyNectar, Inc. - 16, 17.44NectarNeurolens, Inc. - 16, 16.81NeurolensNew Mexico Tech University Research Park Corporation - 16, 19.06New Mexico Tech U…Newave Pharmaceutical Inc. - 16, 16.31Newave Pharmaceut…Newco Enterprises, Inc. - 16, 13.94Newco EnterprisesNeozyme International, Inc. - 16, 19.12Neozyme Internati…
Neozyme vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neozyme's grants concentrate

Neozyme International, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 81.3% of grants classified under A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2017. By volume, Neozyme sits between Namuga Co., Ltd. and Newco Enterprises, Inc..

Neozyme's three-year grant acceleration

Neozyme International, Inc. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Neozyme's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Neozyme holds 16 patents at rank #17,946, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Neozyme

By rank, the assignees closest to #17,946 in granted patent volume.

Leaders in A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…)

Other assignees with the most granted patents in Neozyme's primary technology class.

Neozyme's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2017201920202021202320242025 5
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Neozyme International, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 6.3%
2019 1 6.3%
2020 3 18.8%
2021 1 6.3%
2023 3 18.8%
2024 2 12.5%
2025partial year 5 31.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Neozyme International, Inc.'s patent record in context - here's where to go next.

  • Neozyme International, Inc.'s lead technology class is A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators), 81.3% of its portfolio - see every assignee active in that class. Explore A01N
  • Ranked #17,933 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Neozyme International, Inc. against Namuga Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.